Published in Lupus on January 01, 2007
Vitamin D levels and response to biphosphonates in postmenopausal women receiving glucocorticoid therapy. Osteoporos Int (2014) 5.05
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum Mol Genet (2009) 1.73
Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease. J Clin Rheumatol (2008) 1.54
STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis (2008) 1.42
[Intolerance to hydroxychloroquine marketed in Spain (Dolquine) in patients with autoimmune conditions]. Rev Clin Esp (2004) 1.40
Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun (2006) 1.22
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians. Ann Rheum Dis (2009) 1.06
Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus. Rheumatology (Oxford) (2005) 1.03
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann Rheum Dis (2010) 1.02
A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype. Ann Rheum Dis (2008) 0.95
Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis. Genes Immun (2012) 0.92
Late-onset neutropenia following rituximab treatment in patients with autoimmune diseases. Br J Dermatol (2007) 0.92
Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus. Tissue Antigens (2007) 0.90
A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators. Arthritis Rheum (2012) 0.89
Ileitis terminalis in a patient with Henoch-Schönlein purpura. Dig Dis Sci (1999) 0.89
The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype. Ann Rheum Dis (2008) 0.89
Design and validation of a new image analysis method for automatic quantification of interstitial fibrosis and glomerular morphometry. Lab Invest (1998) 0.87
Efficacy of cognitive behavioural therapy for the treatment of chronic stress in patients with lupus erythematosus: a randomized controlled trial. Psychother Psychosom (2010) 0.84
Urticaria and angioedema in a patient with Behçet's disease treated with adalimumab. Clin Exp Rheumatol (2006) 0.84
Study of a functional polymorphism in the p53 gene in systemic lupus erythematosus: lack of replication in a Spanish population. Lupus (2006) 0.83
No primary association of MICA polymorphism with systemic lupus erythematosus. Rheumatology (Oxford) (2006) 0.82
Inflammatory pseudotumor of lymph nodes with focal infiltration in liver and spleen. Dig Dis Sci (2003) 0.82
Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren's syndrome. Lupus (2008) 0.82
Association study of IRAK-M and SIGIRR genes with SLE in a large European-descent population. Lupus (2012) 0.81
Role of poly (ADP-ribose) polymerase in kidney transplant and its relationship with delayed renal function: multivariate analysis. Transplant Proc (2005) 0.81
Digital flexion contracture and severe carpal tunnel syndrome due to tophaceus infiltration of wrist flexor tendon: first manifestation of gout. Orthopedics (2011) 0.81
No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus. Lupus (2009) 0.80
Gingival overgrowth induced by nifedipine and cyclosporin A. Clinical and morphometric study with image analysis. J Clin Periodontol (1995) 0.80
Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus. Clin Exp Rheumatol (2009) 0.80
Immunohistochemical study of 30 cases of cyclosporin A-induced gingival overgrowth. J Periodontol (1994) 0.80
Study of two polymorphisms of the MHC2TA gene with systemic lupus erythematosus. Rheumatology (Oxford) (2007) 0.79
Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus. Ann Rheum Dis (2005) 0.79
Role of intrarenal endothelin 1, endothelin 3, and angiotensin II expression in chronic cyclosporin A nephrotoxicity in rats. Exp Nephrol (2000) 0.79
Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death. Medicine (Baltimore) (2015) 0.79
Relationship between P-glycoprotein expression and cyclosporin A in kidney. An immunohistological and cell culture study. Am J Pathol (1995) 0.78
Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits. Am J Pathol (1997) 0.78
Vitamin D deficiency in a cohort of patients with systemic lupus erythematous from the South of Spain. Lupus (2010) 0.78
Immunohistochemical quantification of leukocyte subsets in the long-term prognosis of kidney transplants. Transplant Proc (1998) 0.78
[Paniculitis, polyarthritis and pancreatitis]. Rev Clin Esp (2008) 0.78
Poly(ADP-ribose) polymerase expression in kidney transplantation: from alfa (alpha) to Omega (Omega). Transplant Proc (2007) 0.77
Refractory chronic erythema nodosum successfully treated with adalimumab. J Eur Acad Dermatol Venereol (2007) 0.77
Recalcitrant, recurrent aphthous stomatitis successfully treated with adalimumab. J Eur Acad Dermatol Venereol (2008) 0.77
Stress as a predictor of cognitive functioning in lupus. Lupus (2006) 0.77
Role of poly-(ADP-ribose) polymerase in transplant acute tubular necrosis and its relationship with delayed renal function. Transplant Proc (2005) 0.77
Correlation of morphological findings with functional reserve in the aging donor: role of the poly (ADP-ribose) polymerase. Transplant Proc (2004) 0.77
Raynaud's phenomenon and pulmonary arterial hypertension. Lupus (2008) 0.75
Stroke prevention. Should we use perindopril? J Neurol (2003) 0.75
Utility of HLA typing in the differential diagnosis of severe aphthosis and Behçet's disease. Dermatology (2000) 0.75
Desmin-negative intranodal leiomyoma. Am J Clin Pathol (1992) 0.75
Severe Raynaud syndrome induced by adjuvant interferon alfa in metastatic melanoma. Curr Oncol (2010) 0.75
Diffuse sclerosing papillary carcinoma of the thyroid. Clin Endocrinol (Oxf) (1991) 0.75
Endocarditis due to Streptococcus agalactiae: a favorable outcome with conservative treatment. Int J Cardiol (1990) 0.75
[Experience with rituximab in the treatment of systemic erythematosus lupus]. Reumatol Clin (2008) 0.75
[Necrotizing systemic sarcoidosis with pulmonary and central nervous system involvement]. An Med Interna (2008) 0.75
No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and Henoch-Schönlein purpura. Tissue Antigens (2013) 0.75
P-glycoprotein expression in acute kidney graft rejection. Transplant Proc (1998) 0.75
Langerhans' cells and prognosis of thyroid carcinoma. Am J Clin Pathol (1989) 0.75
First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study. Clin Rheumatol (2017) 0.75
Efalizumab for subacute cutaneous lupus: report of two different outcomes. Lupus (2009) 0.75
Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab. Eur J Intern Med (2008) 0.75
Presence of cytomegalovirus genome and leucocyte subsets in renal transplant biopsies. Relationship with prognosis. Pathol Res Pract (1994) 0.75
[Medullary carcinoma of the thyroid and radiotherapy]. Med Clin (Barc) (1989) 0.75
A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis. Clin Exp Rheumatol (2013) 0.75